Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ossification, Heterotopic | 24 | 2020 | 235 | 6.430 |
Why?
|
Lymphatic Vessels | 4 | 2023 | 358 | 1.790 |
Why?
|
Lymphedema | 4 | 2023 | 524 | 1.650 |
Why?
|
Burns | 17 | 2020 | 1866 | 1.540 |
Why?
|
Wounds and Injuries | 12 | 2019 | 2477 | 1.330 |
Why?
|
Mammaplasty | 5 | 2019 | 1240 | 1.180 |
Why?
|
Mesenchymal Stem Cells | 13 | 2020 | 1634 | 1.170 |
Why?
|
Wound Healing | 13 | 2020 | 2788 | 1.080 |
Why?
|
Bone Morphogenetic Protein Receptors | 2 | 2017 | 46 | 1.070 |
Why?
|
Osteogenesis | 12 | 2018 | 1271 | 1.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 3 | 2023 | 367 | 1.010 |
Why?
|
Osteoblasts | 5 | 2019 | 1142 | 0.990 |
Why?
|
Mastectomy | 6 | 2022 | 1832 | 0.970 |
Why?
|
Breast Implantation | 2 | 2017 | 223 | 0.860 |
Why?
|
X-Ray Microtomography | 7 | 2016 | 443 | 0.800 |
Why?
|
Breast Implants | 2 | 2017 | 410 | 0.800 |
Why?
|
Breast Neoplasms | 10 | 2023 | 21025 | 0.790 |
Why?
|
Neovascularization, Physiologic | 3 | 2019 | 1336 | 0.790 |
Why?
|
Muscles | 2 | 2016 | 1581 | 0.770 |
Why?
|
Activin Receptors, Type I | 6 | 2017 | 136 | 0.770 |
Why?
|
Chondrogenesis | 4 | 2016 | 239 | 0.720 |
Why?
|
Cartilage | 3 | 2016 | 806 | 0.610 |
Why?
|
Lymph Node Excision | 5 | 2023 | 1303 | 0.600 |
Why?
|
Spectrum Analysis, Raman | 2 | 2016 | 237 | 0.580 |
Why?
|
Bone Morphogenetic Proteins | 4 | 2016 | 841 | 0.580 |
Why?
|
Burns, Electric | 1 | 2016 | 40 | 0.540 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2017 | 81 | 0.540 |
Why?
|
Bone and Bones | 3 | 2016 | 2560 | 0.530 |
Why?
|
Myositis Ossificans | 1 | 2016 | 77 | 0.520 |
Why?
|
Skin Transplantation | 3 | 2017 | 1083 | 0.510 |
Why?
|
Arm Injuries | 1 | 2017 | 156 | 0.510 |
Why?
|
Tendons | 2 | 2016 | 552 | 0.500 |
Why?
|
Tenotomy | 6 | 2016 | 55 | 0.490 |
Why?
|
Endothelial Cells | 2 | 2019 | 3539 | 0.480 |
Why?
|
Achilles Tendon | 6 | 2016 | 179 | 0.480 |
Why?
|
Gene Targeting | 2 | 2017 | 839 | 0.480 |
Why?
|
Stress, Mechanical | 1 | 2019 | 1666 | 0.470 |
Why?
|
Mastectomy, Subcutaneous | 1 | 2014 | 56 | 0.440 |
Why?
|
Median Neuropathy | 1 | 2012 | 7 | 0.430 |
Why?
|
Abdomen | 2 | 2016 | 1130 | 0.430 |
Why?
|
Disease Models, Animal | 16 | 2020 | 18137 | 0.430 |
Why?
|
Cicatrix | 1 | 2019 | 782 | 0.420 |
Why?
|
Stem Cell Transplantation | 3 | 2016 | 1599 | 0.420 |
Why?
|
Nipples | 1 | 2014 | 221 | 0.410 |
Why?
|
Free Tissue Flaps | 1 | 2016 | 327 | 0.400 |
Why?
|
Device Removal | 1 | 2017 | 636 | 0.400 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 621 | 0.390 |
Why?
|
Incidental Findings | 1 | 2016 | 698 | 0.380 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 730 | 0.380 |
Why?
|
Mice, Inbred C57BL | 19 | 2023 | 22023 | 0.380 |
Why?
|
SOX9 Transcription Factor | 3 | 2016 | 145 | 0.370 |
Why?
|
Blood Vessels | 1 | 2016 | 1112 | 0.360 |
Why?
|
Hamartoma | 1 | 2012 | 235 | 0.360 |
Why?
|
Integrases | 4 | 2019 | 516 | 0.360 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1139 | 0.360 |
Why?
|
Mice | 28 | 2024 | 81208 | 0.340 |
Why?
|
Neutrophils | 2 | 2019 | 3767 | 0.340 |
Why?
|
Animals | 37 | 2024 | 167963 | 0.330 |
Why?
|
Axilla | 2 | 2023 | 626 | 0.320 |
Why?
|
Signal Transduction | 10 | 2019 | 23376 | 0.320 |
Why?
|
Lymphangiogenesis | 2 | 2022 | 172 | 0.320 |
Why?
|
Gastric Bypass | 1 | 2017 | 829 | 0.310 |
Why?
|
Cell Lineage | 1 | 2016 | 2533 | 0.290 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2058 | 0.290 |
Why?
|
Preoperative Care | 1 | 2016 | 2256 | 0.290 |
Why?
|
Cell Movement | 1 | 2019 | 5206 | 0.290 |
Why?
|
Leptin | 1 | 2015 | 1591 | 0.290 |
Why?
|
Survival Analysis | 2 | 2017 | 10182 | 0.290 |
Why?
|
Mice, Transgenic | 7 | 2020 | 9530 | 0.280 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2014 | 1096 | 0.280 |
Why?
|
Fibrosis | 4 | 2023 | 2042 | 0.270 |
Why?
|
Hernia, Ventral | 3 | 2014 | 214 | 0.270 |
Why?
|
Obesity, Morbid | 1 | 2017 | 1287 | 0.260 |
Why?
|
Muscle, Skeletal | 6 | 2023 | 4925 | 0.260 |
Why?
|
Stem Cells | 2 | 2016 | 3523 | 0.260 |
Why?
|
Models, Genetic | 1 | 2016 | 3442 | 0.260 |
Why?
|
Muscular Diseases | 2 | 2023 | 551 | 0.260 |
Why?
|
Weight Loss | 1 | 2017 | 2686 | 0.260 |
Why?
|
Cell Differentiation | 9 | 2024 | 11481 | 0.250 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2023 | 3484 | 0.250 |
Why?
|
Patient Selection | 1 | 2017 | 4283 | 0.240 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2315 | 0.240 |
Why?
|
SEER Program | 3 | 2015 | 1530 | 0.240 |
Why?
|
Patient Compliance | 1 | 2015 | 2688 | 0.240 |
Why?
|
Bone Regeneration | 2 | 2019 | 432 | 0.230 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.220 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7806 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 67 | 0.220 |
Why?
|
Hindlimb | 2 | 2016 | 510 | 0.220 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 169 | 0.220 |
Why?
|
Health Care Costs | 1 | 2016 | 3258 | 0.220 |
Why?
|
Microsurgery | 3 | 2020 | 796 | 0.210 |
Why?
|
Regeneration | 4 | 2023 | 1506 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 200 | 0.210 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 61 | 0.210 |
Why?
|
Graft Rejection | 2 | 2015 | 4426 | 0.210 |
Why?
|
Sternum | 2 | 2014 | 175 | 0.190 |
Why?
|
Humans | 49 | 2024 | 760621 | 0.190 |
Why?
|
Upper Extremity | 2 | 2023 | 661 | 0.180 |
Why?
|
PPAR gamma | 1 | 2023 | 484 | 0.180 |
Why?
|
Arm | 1 | 2023 | 583 | 0.180 |
Why?
|
Cells, Cultured | 6 | 2024 | 18957 | 0.170 |
Why?
|
Female | 29 | 2023 | 391270 | 0.160 |
Why?
|
Sirolimus | 2 | 2016 | 1547 | 0.160 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2015 | 1791 | 0.160 |
Why?
|
Virilism | 1 | 2018 | 28 | 0.160 |
Why?
|
Quality of Life | 2 | 2022 | 13308 | 0.160 |
Why?
|
Th2 Cells | 1 | 2024 | 1047 | 0.160 |
Why?
|
Registries | 1 | 2015 | 8469 | 0.160 |
Why?
|
Surgical Flaps | 4 | 2020 | 1669 | 0.150 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2019 | 256 | 0.150 |
Why?
|
Genitalia, Female | 1 | 2018 | 147 | 0.150 |
Why?
|
Adipose Tissue | 4 | 2022 | 3301 | 0.140 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2017 | 97 | 0.140 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2023 | 1928 | 0.140 |
Why?
|
Arthroplasty | 2 | 2016 | 313 | 0.140 |
Why?
|
Frostbite | 1 | 2017 | 24 | 0.140 |
Why?
|
Smad5 Protein | 1 | 2016 | 26 | 0.140 |
Why?
|
Aggrecans | 1 | 2016 | 87 | 0.140 |
Why?
|
Mustard Compounds | 1 | 2015 | 4 | 0.130 |
Why?
|
Smad1 Protein | 1 | 2016 | 81 | 0.130 |
Why?
|
Reoperation | 3 | 2017 | 4291 | 0.130 |
Why?
|
Adult | 16 | 2017 | 219994 | 0.130 |
Why?
|
Receptor, TIE-2 | 1 | 2016 | 176 | 0.130 |
Why?
|
Apatites | 1 | 2015 | 19 | 0.130 |
Why?
|
Phenylpropionates | 1 | 2015 | 35 | 0.130 |
Why?
|
Michigan | 1 | 2016 | 342 | 0.130 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2016 | 158 | 0.130 |
Why?
|
Nerve Compression Syndromes | 1 | 2017 | 160 | 0.130 |
Why?
|
Osteocalcin | 1 | 2016 | 274 | 0.130 |
Why?
|
Mediastinitis | 1 | 2015 | 49 | 0.130 |
Why?
|
Male | 25 | 2023 | 359744 | 0.130 |
Why?
|
Receptors, Retinoic Acid | 1 | 2016 | 224 | 0.130 |
Why?
|
Aromatase Inhibitors | 1 | 2019 | 511 | 0.130 |
Why?
|
Sex Reassignment Surgery | 1 | 2018 | 156 | 0.130 |
Why?
|
Hair Follicle | 1 | 2017 | 210 | 0.120 |
Why?
|
Hip | 1 | 2016 | 251 | 0.120 |
Why?
|
Joints | 1 | 2016 | 321 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2024 | 1155 | 0.120 |
Why?
|
Mice, Obese | 1 | 2015 | 420 | 0.120 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2014 | 54 | 0.120 |
Why?
|
Contracture | 1 | 2017 | 235 | 0.120 |
Why?
|
Internal Fixators | 1 | 2015 | 183 | 0.120 |
Why?
|
Sternotomy | 1 | 2015 | 128 | 0.120 |
Why?
|
Tissue Transplantation | 1 | 2015 | 128 | 0.120 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 802 | 0.120 |
Why?
|
Adaptive Immunity | 2 | 2016 | 726 | 0.120 |
Why?
|
Middle Aged | 16 | 2017 | 220352 | 0.110 |
Why?
|
Rectus Abdominis | 1 | 2014 | 102 | 0.110 |
Why?
|
Luminescent Measurements | 1 | 2015 | 378 | 0.110 |
Why?
|
Body Surface Area | 1 | 2014 | 197 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 3 | 2019 | 5643 | 0.110 |
Why?
|
Luminescent Proteins | 1 | 2016 | 835 | 0.110 |
Why?
|
Calciphylaxis | 1 | 2015 | 130 | 0.110 |
Why?
|
Elbow Joint | 1 | 2017 | 356 | 0.110 |
Why?
|
Pericytes | 1 | 2016 | 293 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6544 | 0.110 |
Why?
|
Aged | 12 | 2017 | 169152 | 0.110 |
Why?
|
Abdominal Wall | 1 | 2014 | 165 | 0.110 |
Why?
|
NFATC Transcription Factors | 1 | 2015 | 381 | 0.110 |
Why?
|
Bone Density | 2 | 2016 | 3534 | 0.100 |
Why?
|
Mice, Knockout | 3 | 2017 | 14372 | 0.100 |
Why?
|
Muscular Atrophy | 1 | 2015 | 331 | 0.100 |
Why?
|
Cell Proliferation | 3 | 2019 | 10446 | 0.100 |
Why?
|
Blast Injuries | 1 | 2016 | 322 | 0.100 |
Why?
|
Debridement | 2 | 2017 | 492 | 0.100 |
Why?
|
Life Expectancy | 1 | 2019 | 1248 | 0.100 |
Why?
|
Recurrence | 2 | 2016 | 8482 | 0.100 |
Why?
|
Median Nerve | 1 | 2012 | 132 | 0.100 |
Why?
|
Bone Diseases, Metabolic | 1 | 2016 | 409 | 0.100 |
Why?
|
Retrospective Studies | 11 | 2017 | 80372 | 0.100 |
Why?
|
Abdominal Fat | 1 | 2014 | 223 | 0.100 |
Why?
|
Tendon Injuries | 1 | 2015 | 327 | 0.100 |
Why?
|
Apyrase | 1 | 2014 | 373 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1705 | 0.100 |
Why?
|
Cadherins | 1 | 2016 | 898 | 0.100 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2017 | 708 | 0.100 |
Why?
|
Rats | 2 | 2019 | 23711 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 12293 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1529 | 0.090 |
Why?
|
Young Adult | 6 | 2017 | 58741 | 0.090 |
Why?
|
Animals, Newborn | 1 | 2016 | 2672 | 0.090 |
Why?
|
Stromal Cells | 1 | 2016 | 1326 | 0.090 |
Why?
|
Inflammation | 3 | 2019 | 10756 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2575 | 0.090 |
Why?
|
Range of Motion, Articular | 1 | 2017 | 1583 | 0.090 |
Why?
|
Radiotherapy | 1 | 2017 | 1504 | 0.090 |
Why?
|
Ligands | 1 | 2017 | 3276 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2014 | 829 | 0.090 |
Why?
|
Methylene Blue | 1 | 2010 | 157 | 0.090 |
Why?
|
Gene Regulatory Networks | 2 | 2015 | 1741 | 0.090 |
Why?
|
Skin | 3 | 2019 | 4466 | 0.080 |
Why?
|
Follow-Up Studies | 3 | 2016 | 39261 | 0.080 |
Why?
|
Prognosis | 3 | 2015 | 29658 | 0.080 |
Why?
|
Choice Behavior | 1 | 2015 | 821 | 0.080 |
Why?
|
Piperazines | 1 | 2019 | 2525 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4902 | 0.080 |
Why?
|
Postoperative Complications | 4 | 2015 | 15697 | 0.080 |
Why?
|
Cytokines | 3 | 2024 | 7343 | 0.080 |
Why?
|
Mastectomy, Segmental | 1 | 2014 | 972 | 0.080 |
Why?
|
Models, Animal | 1 | 2015 | 2117 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 2 | 2016 | 8158 | 0.080 |
Why?
|
Chimera | 1 | 2009 | 453 | 0.080 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 1993 | 0.080 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2010 | 153 | 0.080 |
Why?
|
Coloring Agents | 1 | 2010 | 562 | 0.070 |
Why?
|
Tumor Burden | 1 | 2014 | 1895 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1796 | 0.070 |
Why?
|
Decompression, Surgical | 1 | 2012 | 604 | 0.070 |
Why?
|
Pyridines | 1 | 2019 | 2879 | 0.070 |
Why?
|
Lymph Nodes | 2 | 2020 | 3486 | 0.070 |
Why?
|
Phantoms, Imaging | 1 | 2016 | 2512 | 0.070 |
Why?
|
Fractures, Bone | 1 | 2019 | 2041 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4122 | 0.070 |
Why?
|
Fibroblasts | 1 | 2016 | 4090 | 0.070 |
Why?
|
Propensity Score | 1 | 2014 | 1928 | 0.070 |
Why?
|
Acute Disease | 1 | 2017 | 7269 | 0.070 |
Why?
|
Macrophages | 2 | 2020 | 5745 | 0.070 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2943 | 0.070 |
Why?
|
Time Factors | 3 | 2017 | 40165 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36290 | 0.060 |
Why?
|
Suture Techniques | 1 | 2010 | 790 | 0.060 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14660 | 0.060 |
Why?
|
Surgical Wound Infection | 1 | 2014 | 1527 | 0.060 |
Why?
|
Body Composition | 1 | 2014 | 2419 | 0.060 |
Why?
|
Adolescent | 4 | 2017 | 87810 | 0.060 |
Why?
|
Drainage | 1 | 2010 | 1161 | 0.060 |
Why?
|
RNA | 1 | 2014 | 2722 | 0.060 |
Why?
|
Fascia | 2 | 2014 | 141 | 0.060 |
Why?
|
Gene Expression | 1 | 2016 | 7588 | 0.060 |
Why?
|
Survival Rate | 2 | 2015 | 12808 | 0.050 |
Why?
|
Intercostal Nerves | 1 | 2022 | 27 | 0.050 |
Why?
|
Porosity | 1 | 2023 | 349 | 0.050 |
Why?
|
Calcium | 1 | 2015 | 5725 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8552 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 20509 | 0.050 |
Why?
|
Preoperative Period | 2 | 2014 | 555 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3476 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2023 | 748 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2015 | 58995 | 0.050 |
Why?
|
Risk Factors | 4 | 2023 | 74359 | 0.050 |
Why?
|
Lymphatic System | 1 | 2022 | 254 | 0.050 |
Why?
|
Aging | 2 | 2023 | 8651 | 0.050 |
Why?
|
Subcutaneous Fat | 2 | 2014 | 393 | 0.050 |
Why?
|
Random Allocation | 2 | 2015 | 2394 | 0.050 |
Why?
|
Denervation | 1 | 2022 | 277 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2015 | 12766 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12159 | 0.040 |
Why?
|
Biopsy, Needle | 2 | 2015 | 1630 | 0.040 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2882 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2017 | 26181 | 0.040 |
Why?
|
Adipogenesis | 1 | 2022 | 358 | 0.040 |
Why?
|
Hemodynamics | 1 | 2010 | 4174 | 0.040 |
Why?
|
Gene Expression Regulation | 4 | 2020 | 11903 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11152 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9467 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12531 | 0.040 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 536 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8950 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16546 | 0.040 |
Why?
|
DNA Nucleotidyltransferases | 1 | 2019 | 176 | 0.040 |
Why?
|
Founder Effect | 1 | 2019 | 186 | 0.040 |
Why?
|
Education, Medical | 1 | 2010 | 1727 | 0.040 |
Why?
|
Infant | 2 | 2017 | 36060 | 0.040 |
Why?
|
Child, Preschool | 2 | 2017 | 42063 | 0.040 |
Why?
|
Rewarming | 1 | 2017 | 64 | 0.030 |
Why?
|
Transcription Factors | 1 | 2016 | 12103 | 0.030 |
Why?
|
Algorithms | 1 | 2017 | 13981 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2020 | 608 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2023 | 928 | 0.030 |
Why?
|
United States | 2 | 2015 | 72461 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2016 | 208 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17790 | 0.030 |
Why?
|
Stilbenes | 1 | 2016 | 155 | 0.030 |
Why?
|
Sampling Studies | 1 | 2017 | 613 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2017 | 65017 | 0.030 |
Why?
|
Smad Proteins, Receptor-Regulated | 1 | 2014 | 8 | 0.030 |
Why?
|
Foot Injuries | 1 | 2017 | 149 | 0.030 |
Why?
|
Obesity | 2 | 2014 | 12922 | 0.030 |
Why?
|
Transplantation, Isogeneic | 1 | 2015 | 248 | 0.030 |
Why?
|
Cardiac Surgical Procedures | 1 | 2010 | 3620 | 0.030 |
Why?
|
Skull | 1 | 2019 | 815 | 0.030 |
Why?
|
Child | 3 | 2017 | 79806 | 0.030 |
Why?
|
Phagocytosis | 1 | 2020 | 1535 | 0.030 |
Why?
|
Hand Injuries | 1 | 2017 | 239 | 0.030 |
Why?
|
Blood Cells | 1 | 2016 | 305 | 0.030 |
Why?
|
Risk Assessment | 4 | 2017 | 24123 | 0.030 |
Why?
|
Chimerism | 1 | 2014 | 155 | 0.030 |
Why?
|
Hydrolysis | 1 | 2014 | 665 | 0.030 |
Why?
|
Morphogenesis | 1 | 2017 | 740 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2017 | 1033 | 0.030 |
Why?
|
Multiple Trauma | 1 | 2015 | 369 | 0.030 |
Why?
|
Motivation | 1 | 2022 | 1993 | 0.030 |
Why?
|
Gender Identity | 1 | 2018 | 698 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2023 | 1870 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2015 | 1763 | 0.030 |
Why?
|
Lower Extremity | 1 | 2020 | 1194 | 0.030 |
Why?
|
Bone Development | 1 | 2015 | 472 | 0.030 |
Why?
|
Pain Measurement | 1 | 2022 | 3528 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11071 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1721 | 0.020 |
Why?
|
Surgical Mesh | 1 | 2014 | 311 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2015 | 1089 | 0.020 |
Why?
|
Counseling | 1 | 2018 | 1548 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3075 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 29932 | 0.020 |
Why?
|
Logistic Models | 2 | 2014 | 13314 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2015 | 894 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2014 | 608 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2014 | 1254 | 0.020 |
Why?
|
Administration, Topical | 1 | 2010 | 697 | 0.020 |
Why?
|
Reference Values | 1 | 2015 | 4925 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15289 | 0.020 |
Why?
|
Iliac Artery | 1 | 2009 | 344 | 0.020 |
Why?
|
Bone Density Conservation Agents | 1 | 2015 | 796 | 0.020 |
Why?
|
Radial Artery | 1 | 2009 | 196 | 0.020 |
Why?
|
Peptides | 1 | 2020 | 4354 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5039 | 0.020 |
Why?
|
Spine | 1 | 2014 | 1111 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3568 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6238 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5870 | 0.020 |
Why?
|
Pyrazoles | 1 | 2016 | 1999 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6068 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2282 | 0.020 |
Why?
|
Femoral Artery | 1 | 2009 | 835 | 0.020 |
Why?
|
Graft Survival | 1 | 2014 | 3794 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8313 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9631 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4048 | 0.010 |
Why?
|
Pain | 1 | 2017 | 5066 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10547 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3763 | 0.010 |
Why?
|
Comorbidity | 1 | 2014 | 10551 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14495 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 6180 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20080 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22053 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21392 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54303 | 0.010 |
Why?
|